Dr. Y. Nalini-Radiation Oncologist

Dr. Y. Nalini, Radiation Oncologist

MBBS, MD, DNB (RT)

Specializations

  • Radiation Oncologist

Expertises

  • Breast Cancers
  • Gastrointestinal Cancers
  • Gynecological Cancer
  • Internal Modulated Radiotherapy
  • Liver and Lung Cancers
  • Pediatric Cancers
  • Rapid Arc Radiotherapy
  • Sarcomas and Brain Tumor
  • Stereotactic Body Radiation Therapy

Qualifications

  • MBBS - Gandhi Medical College - 1983 - Hyderabad verified-badgeVerified
  • DNB - Radiotherapy - National Board of Examination - 1994 - New Delhi verified-badgeVerified
  • MD - Radiotherapy - Osmania Medical College - 1997 - Hyderabad verified-badgeVerified
  • FIUCS - Royal Marsden Hospital - 2000 - London Verified
  • Training in Intensity Modulated Radiation Therapy - Anderson Cancer Hospital - Houston Verified
  • Training in Image Guided Radiation Therapy - Anderson Cancer Hospital - Houston Verified

Experiences

  • Assistant Professor - Radiotherapy Osmania Medical College - Hyderabad - 1994 - 2001
  • Assistant Professor Rangaraya Medical College - Kakinada - Jun 2001 - Sep 2003
  • Professor - Radiotherapy Government Medical College - Anantapur - Sep 2003 - Dec 2004
  • Professor - Radiotherapy MNJ Institute of Oncology and RCC - Hyderabad - Dec 2004 - Dec 2008
  • Consultant Radiation Oncologist Apollo Cancer Hospitals - Hyderabad
  • Consultant Radiation Oncologist Yashoda Hospitals - Somajiguda - 2009 - Currently Working
  • Consultant Radiation Oncologist Apollo Hospitals - Jubliee Hills - Currently Working

Registrations

  • 10548 HMC Hyderabad Medical Council 1983 verified-badgeVerified

Memberships

  • Indian Society of Oncology
  • Indian Medical Association
  • Union for International Cancer Congress
  • Association of Radiation Oncologists of India (AROI)
  • American Society for Therapeutic Radiology and Oncology

Paper Presentations

  • Co - Investigator in Multicenteric Five Arm Study for Efficacy and Toxicity of Wobe Mugose E in Reducing Radiation Toxicity
  • Co - Investigator in ATLAS Study : International Adjuvant Tamoxifen Longer Against Shorter Breast Cancer Treatment Trial
  • Open, Uncontrolled, Multicentre, Phase II Asia/Australian Study of Erbitus'R' (Cetuximab) in Combination with Irinotecan in Patients with Metastatic Colorectal Adenocarcinoma Expressing the Epidermal Growth Factor Receptor (EGFR) and having Progressed on Defined Irinotecan - based Regimen as Most Recent Treatment
  • Trial Investigator in TOGA Study (NCT01041404) - A Study of Herceptin (Trastuzumab) in Combination with Chemotherapy Compared with Chemotherapy Alone in Patients with HER2-Positive Advanced Gastric Cancer
  • An Open Label Randomized Phase II Study of Two Different Dosing Regimens of Capecitabine in Combination with Intravenous Docetaxel (Q3W) in Patients with Locally Advanced Metastatic Breast Cancer
  • A Randomized, Open Label, Multicentre Study of VELCADE with Rituximab or Rituximab Alone in Subjects with Relapsed or Refractory, Rituximab Naive or Sensitive Follicular B - Cell Non -Hodgkin's Lymphoma. Protocol 26866138-LYM-3001; Phase 3
  • A Phase III, Randomized, Double-Blinded, Multi-Centre Study to Assess the Efficacy of Docetaxel in Combination with ZD6474 (ZACTIMA ) Versus Docetaxel in Combination with Placebo in Patients with Locally Advanced or Metastatic (Stage IIIb-IV) Non - Small Cell Lung Cancer After Failure of 1st Line Anti - Cancer Therapy
  • Multiple Myeloma-A Phase I/II a, Open - Label, Dose - Escalation Study to Determine the Safety and Tolerance, and Preliminary Activity of Intravenous High-Dose Fluphenazine HCI in Patients with Advanced Multiple Myeloma
  • Phase III Study of Lucanix tm (Belagenpumatucel - L) in Advanced Non-Small Cell Lung Cancer: An International Multicenter, Randomized, Double-Blinded, Placebo controlled Study of Lucanix tm Maintenance Therapy for Stages III/IV NSCLC Subjects Who have Responded to or Have Stable Disease Following One Regimen of Front-line, Platinum-based Combination Chemotherapy
  • Yadala Nalini, Vivek Yadala, Sunil Devika, Swamy S Thirumalai. Rapid arc Radiotherapy in A Patient with Bilateral Breast Carcinoma - 10 year follow up. International Journal of Contemporary Medical Research. Research ISSN (Online): 2393-915X; (Print): 2454-7379 | ICV: 98.46 | Volume 6 | Issue 12 | December 2019
  • A Retrospective Study of Thousand Pap Smears at Tertiary Care Centre. International Journal of Contemporary Medical Research. Research ISSN (Online): 2393-915X; (Print): 2454-7379 | ICV: 77.83 | Volume 4 | Issue 12 | December 2017
  • A Rare Case of Fever of Unknown Origin : Subcutaneous Panniculitis like T - Cell Lymphoma BMJ Case Reports 2015.doi:10-1136 / bcr-2015-211355
  • Multiple Aneurysms and Rosai - Dorfman`s Disease Association or Coincidence, BMJ Case Reports 2015;doi:10.1136/bcr-2015-212189
  • Huge Mediastinal Mass with Minimal Symptoms : Thymolipoma. BMJ Case Reports 2011;doi:10.1136/bcr.02.2010.8984
  • Analysis of Patients Attending Headache Clinic : Indian Experience. Cephaialgia May 2000,20(4) 307
  • Parasites and Headache Indian Experience, Headache : The Journal of Head and Face Pain, June 2002
  • Headache Scenario South India (Tropical Cephalalgia) Headache: The Journal of Head and Face Pain, Vol 42 Issue(5) - 2002

Report an error

Dr. Y. Nalini Practice Location

location-icon

Road No 72, Film Nagar

Opp Bharatiya Vidya Bhavan School

Jubliee Hills, Hyderabad

Get directions

time-icon

OP Timings

On Call
...

Fee : 800

location-icon

Rajbhavan Road

Matha Nagar

Somajiguda, Hyderabad

Get directions

time-icon

OP Timings

Mon - Sat

10:00 am - 02:00 pm
...

Fee : 600

Write a review for Dr. Y. Nalini

Which clinic or hospital you visited

empty

I Recommend this Doctor for

How was your experience

Write your experience aboutDr. Y. Nalini

skedoc | Right Doctor Right Advice

skedoc brings you healthcare that is relevant to your specific health needs. We make finding the Right Doctor and the Right Advice extremely easy.

  • Home
  • Search
  • Doctors
  • Hospitals